Red Blood Cells

INTERCEPT Blood System for Red Blood Cells

is under Development

The INTERCEPT Blood System for red blood cells was designed with the following blood safety and availability goals in mind:

  • Reduce the transmission risk for a large spectrum of red blood cell (RBC) pathogens, including agents for which testing does not exist
  • Improve blood availability by reducing donor deferrals
  • Replace gamma irradiation for the prevention of transfusion-associated graft versus host disease (TA-GVHD)
  • Reduce potential transfusion reactions with decreased residual plasma
  • Complete pathogen inactivation safety strategies for all three blood components
  • Compatible with all RBC collection platforms and standard blood processing equipment
  • Process flexibility to enable use of any RBC storage solution
  • Minimise haemoglobin loss
  • No external illumination source or compound removal device
  • Meets the Council of Europe guidelines for leukoreduced RBCs in additive solution